Non-interventional Substudy of ALX-HPP-502 to Assess Natural History of Patients With Juvenile-onset HPP Who Served as Historical Controls in ENB-006-09

Completed

Conditions studied: Hypophosphatasia, Bone Disease

In brief

The purpose of this study is to characterize the natural history of HPP in patients with Juvenile-onset HPP who served as historical controls in ENB-006-09.

Key facts

Study ID

NCT02235493

Run by

Alexion Pharmaceuticals, Inc.

People needed

6

Starts

2014-08-01

Expected to finish

2014-09-01

Last updated by the study team

2019-03-13

Who can join

Age: 5 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Documented informed consent/assent prior to video collection and data abstraction.
• Documented informed consent/assent in Study ALX-HPP-502.
• Patients with juvenile-onset HPP and was selected as a historical-control for Study ENB-006-09.
• Patients with at least 2 videos of basic mobility that were recorded at 2 different clinic visits when the patient was ≥5 to ≤15 ye

You may not qualify if…

• There are no exclusion criteria for this study

Where it is running

• Study site — St Louis, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.